65117-31-9Relevant academic research and scientific papers
PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR
-
Page/Page column 63, (2009/07/18)
The present invention is directed to piperidinyl and piperazinyl derivatives of formula (I) useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of
SUBSTITUTED PIPERAZINES AND PIPERIDINES AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR
-
Page/Page column 28, (2010/11/27)
The invention provides novel non-peptidic NPY Y2 receptor inhibitors useful in treating or preventing: anxiolytic disorders or depression; injured mammalian nerve tissue; conditions responsive to treatment through administration of a neurotrophic factor; neurological disorders; bone loss; substance related disorders; sleep/wake disorders; cardiovascular disease; obesity; or an obesity-related disorder. Compounds of the invention are also useful in modulating endocrine functions, particularly endocrine functions controlled by the pituitary and hypothalamic glands, and are therefore useful in the treatment or prevention of inovulation and infertility.
Novel amide-based chain transfer agent for reversible addition fragmentation chain transfer polymerization
Takolpuckdee, Pittaya,Mars, Craig A.,Perrier, Sebastien,Archibald, Stephen J.
, p. 1057 - 1060 (2007/10/03)
A novel chain transfer agent (CTA), S-diethylcarbamoylphenylmethyl dithiobenzoate (DCPDB), based on an amide functionality was analyzed, to mediate the polymerization of styrene and acrylamide derivatives. The reversible addition fragmentation chain trans
